Skip to main content
. 2019 Oct 8;25(6):479–e899. doi: 10.1634/theoncologist.2019-0608
Drug 1
Generic/Working Name ETBX‐011
Trade Name None
Company Name Etubics (a wholly owned subsidiary of ImmunityBio)
Drug Type Vaccine
Drug Class Immune therapy
Dose 5 × 1011 viral particles per flat dose
Route Other; subcutaneous
Schedule of Administration

ETBX‐011 = CEA

Every 3 weeks for three doses, then every 8 weeks for 1 year

Drug 2
Generic/Working Name ETBX‐051
Trade Name None
Company Name Etubics (a wholly owned subsidiary of ImmunityBio)
Drug Type Vaccine
Drug Class Immune therapy
Dose 5 × 1011 viral particles per flat dose
Route Other; subcutaneous
Schedule of Administration

ETBX‐061 = MUC1

Every 3 weeks for three doses, then every 8 weeks for 1 year

Drug 3
Generic/Working Name ETBX‐061
Trade Name None
Company Name Etubics (a wholly owned subsidiary of ImmunityBio)
Drug Type Vaccine
Drug Class Immune therapy
Dose 5 × 1011 viral particles per flat dose
Route Other; subcutaneous
Schedule of Administration

ETBX‐051 = brachyury

Every 3 weeks for three doses, then every 8 weeks for 1 year